Open AccessP970: SAFETY AND EFFICACY OF BCMA‐CAR‐T IMMUNE CELLS DERIVED FROM CORD BLOOD IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
Author(s) -
Wang Y.,
Hu X.,
Gao Q.,
Wang H.,
Gao Y.,
Zhang W.,
Ru X.,
Hou L.,
Zhou W.,
Zhang H.,
Zhang Y.,
Wang F.,
Li X.,
Guan F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846748.66048.bc
Subject(s) - medicine , fludarabine , cyclophosphamide , multiple myeloma , cord blood , car t cell therapy , immunogenicity , refractory (planetary science) , cytokine release syndrome , regimen , chemotherapy , oncology , immune system , immunotherapy , immunology , chimeric antigen receptor , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom